Level Four Advisory Services’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$4.79M Buy
16,363
+5,173
+46% +$1.7M 0.16% 176
2025
Q4
$3.92M Sell
11,190
-4,169
-27% -$1.41M 0.13% 202
2025
Q3
$4.96M Sell
15,359
-1,588
-9% -$494K 0.17% 165
2025
Q2
$6.59M Buy
16,947
+950
+6% +$382K 0.24% 113
2025
Q1
$6.96M Buy
15,997
+5,187
+48% +$2.08M 0.29% 93
2024
Q4
$3.99M Sell
10,810
-2,403
-18% -$1.01M 0.16% 164
2024
Q3
$5.36M Buy
13,213
+1,428
+12% +$763K 0.23% 131
2024
Q2
$6.39M Buy
11,785
+6,951
+144% +$3.67M 0.29% 89
2024
Q1
$2.28M Hold
4,834
0.13% 183
2023
Q4
$2.28M Sell
4,834
-399
-8% -$185K 0.13% 181
2023
Q3
$2.28M Buy
5,233
+2,697
+106% +$1.22M 0.15% 166
2023
Q2
$1.13M Buy
2,536
+106
+4% +$48.9K 0.07% 268
2023
Q1
$1.12M Buy
2,430
+824
+51% +$392K 0.07% 260
2022
Q4
$824K Buy
1,606
+459
+40% +$233K 0.06% 285
2022
Q3
$521K Sell
1,147
-2
-0.2% -$957 0.05% 306
2022
Q2
$554K Buy
1,149
+2
+0.2% +$989 0.05% 314
2022
Q1
$563K Buy
1,147
+112
+11% +$51.2K 0.04% 364
2021
Q4
$480K Sell
1,035
-99
-9% -$41.6K 0.04% 399
2021
Q3
$423K Buy
1,134
+175
+18% +$66.5K 0.04% 322
2021
Q2
$366K Sell
959
-127
-12% -$48.5K 0.03% 486
2021
Q1
$390K Buy
1,086
+91
+9% +$29.3K 0.03% 435
2020
Q4
$319K Sell
995
-76
-7% -$23.3K 0.03% 453
2020
Q3
$288K Sell
1,071
-486
-31% -$131K 0.02% 448
2020
Q2
$409K Buy
1,557
+150
+11% +$40K 0.03% 404
2020
Q1
$321K Buy
1,407
+94
+7% +$25.6K 0.04% 379
2019
Q4
$397K Buy
1,313
+417
+47% +$115K 0.02% 414
2019
Q3
$215K Sell
896
-127
-12% -$34.8K 0.02% 464
2019
Q2
$289K Buy
1,023
+123
+14% +$33.6K 0.03% 430
2019
Q1
$258K Sell
900
-41
-4% -$11.9K 0.03% 442
2018
Q4
$247K Buy
941
+208
+28% +$57.2K 0.03% 438
2018
Q3
$201K Buy
+733
New +$190K 0.02% 560

Other funds holding ELV

Level Four Advisory Services's ELV Position: Q1 2026 in Review

Level Four Advisory Services increased its Elevance Health (ELV) stake by 46% in Q1 2026, buying an estimated $1.7M and bringing the position to 16,363 shares worth $4.79M. The position accounts for 0.16% of the portfolio, ranked #176.

Level Four Advisory Services first reported a position in ELV in Q3 2018 and has held it in 31 quarters since. The position peaked at $6.96M in Q1 2025. 1,462 funds tracked by Wall St. Rank hold ELV as of Q1 2026.

  • Level Four Advisory Services held 16,363 shares of Elevance Health worth $4.79M as of Q1 2026.
  • Level Four Advisory Services bought 5,173 Elevance Health shares in Q1 2026, an estimated $1.7M.
  • Elevance Health made up 0.16% of Level Four Advisory Services's portfolio in Q1 2026, its #176 holding.
  • Level Four Advisory Services first reported a position in Elevance Health in Q3 2018 and has held it in 31 quarters since.
  • Level Four Advisory Services's Elevance Health position peaked at $6.96M in Q1 2025.
  • 1,462 funds tracked by Wall St. Rank held Elevance Health as of Q1 2026.

Based on Level Four Advisory Services's 13F filing for Q1 2026, filed 14 May 2026.